Influence of microsatellite instability and KRAS and BRAF mutations on lymph node harvest in stage I-III colon cancers

Molecular Medicine

Volumn 19, Issue 1, 2013, Pages 286-293

  Berg, Marianne ^a   Guriby, Marianne ^b,c   Nordgård, Oddmund ^a   Nedrebø, Bjørn S ^a   Ahlquist, Terje C ^b,c   Smaaland, Rune ^a   Oltedal, Satu ^a   Søreide, Jon Arne ^a,d   Kørner, Hartwig ^a,d   Lothe, Ragnhild A ^b,c   Søreide, Kjetil ^a,d  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; BRAF PROTEIN, HUMAN; KRAS PROTEIN, HUMAN; ONCOPROTEIN; RAS PROTEIN;

AGED; ARTICLE; ASCENDING COLON; CANCER LOCALIZATION; CANCER STAGING; CLINICAL FEATURE; CODON; COLON CANCER; EX VIVO STUDY; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE HARVEST; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; ONCOGENE BRAF; ONCOGENE K RAS; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; ADULT; COLON TUMOR; GENETICS; LYMPH NODE; MIDDLE AGED; MUTATION; PATHOLOGY; PROGNOSIS; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MUTATION; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS; YOUNG ADULT;

EID: 84883791516     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2013.00049     Document Type: Article

References (35)

1. Bilimoria KY, et al. (2008) Adequacy and importance of lymph node evaluation for colon cancer in the elderly. J. Am. Coll. Surg. 206:247-54.
2. Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. (2007) Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J. Natl. Cancer Inst. 99:433-41.
3. Wang J, et al. (2009) Should total number of lymph nodes be used as a quality of care measure for stage III colon cancer? Ann. Surg. 249:559-63.
4. Veen T, et al. (2013) Qualitative and quantitative issues of lymph nodes as prognostic factor in colon cancer. Dig. Surg. 30:1-11.
5. Cianchi F, et al. (2002) Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined. World J. Surg. 26:384-9.
6. Nathan H, et al. (2011) Variation in lymph node assessment after colon cancer resection: patient, surgeon, pathologist, or hospital? J. Gastrointest. Surg. 15:471-9.
7. Shia J, Wang H, Nash GM, Klimstra DS. (2012) Lymph node staging in colorectal cancer: revisiting the benchmark of at least 12 lymph nodes in r0 resection. J. Am. Coll. Surg. 214:348-55.
8. Wright FC, Law CH, Berry S, Smith AJ. (2009) Clinically important aspects of lymph node assessment in colon cancer. J. Surg. Oncol. 99:248-55.
9. Baxter NN. (2009) Is lymph node count an ideal quality indicator for cancer care? J. Surg. Oncol. 99:265-8.
10. Nedrebø B, et al. (2013) Risk factors associated with poor lymph node harvest after colon cancer surgery in a national cohort. Colorectal Dis. 15:e301-8.
11. Søreide K, Nedrebø BS, Søreide JA, Slewa A, Kørner H. (2009) Lymph node harvest in colon cancer: influence of microsatellite instability and proximal tumor location. World J. Surg. 33:2695-703.
12. Belt EJ, et al. (2012) High lymph node yield is related to microsatellite instability in colon cancer. Ann. Surg. Oncol. 19:1222-30.
13. Eveno C, et al. (2010) Association between a high number of isolated lymph nodes in T1 to T4 N0M0 colorectal cancer and the microsatellite instability phenotype. Arch. Surg. 145:12-7.
14. Nordgard O, et al. (2009) Quantitative RT-PCR detection of tumor cells in sentinel lymph nodes isolated from colon cancer patients with an ex vivo approach. Ann. Surg. 249:602-7.
15. Bjugn R, Dirdal HU. (2001) Colorectal cancer: experiences with the use of standardized forms for reporting pathologic-anatomic data. Tidsskr Nor Laegeforen 121:1697-701.
16. Umar A, et al. (2004) Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J. Natl. Cancer Inst. 96:261-8.
17. Gilje B, Heikkila R, Oltedal S, Tjensvoll K, Nordgård O. (2008) High-fidelity DNA polymerase enhances the sensitivity of a peptide nucleic acid clamp PCR assay for K-ras mutations. J. Mol. Diagn. 10:325-31.
18. Oltedal S, et al. (2010) Detection of occult metastases in sentinel lymph nodes from colon cancer patients by K-ras mutation peptide nucleic acid clamp PCR. Ann. Surg. 251:1087-91.
19. Ahlquist T, et al. (2008) RAS signaling in colorectal carcinomas through alteration of RAS, RAF, NF1, and/or RASSF1A. Neoplasia. 10:680-6.
20. Pallant J. (2010) Multiple regression. In: SPSS Survival Manual. McGraw-Hill, London, pp. 148-67.
21. Lang TA, Secic M. (2006) Prediciting values from one or more variables: reporting regression analyses. In: How to Report Statistics in Medicine. Annotated Guidelines for Authors, Editors, and Reviewers. Lang TA, Secic M, Eds. American College of Physicians, Philadelphia, pp. 85-107.
22. Merok MA, et al. (2013) Microsatellite instability has a positive prognostic impact on stage II colorectal cancer after complete resection: results from a large, consecutive Norwegian series. Ann. Oncol. 24:1274-82.
23. Morikawa T, et al. (2012) Predictors of lymph node count in colorectal cancer resections: data from US nationwide prospective cohort studies. Arch. Surg. 8:715-23.
24. Yamauchi M, et al. (2012) Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum. Gut. 61:847-54.
25. Sinicrope FA, Sargent DJ. (2012) Molecular pathways: microsatellite instability in colorectal cancer: prognostic, predictive and therapeutic implications. Clin. Cancer Res. 18:1506-12.
26. Ogino S, et al. (2012) Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from Intergroup Trial CALGB 89803. Clin. Cancer Res. 18:890-900.
27. MacQuarrie E, et al. (2012) Microsatellite instability status does not predict total lymph node or negative lymph node retrieval in stage III colon cancer. Hum. Pathol. 43:1258-64.
28. Yamauchi M, et al. (2012) Colorectal cancer: a tale of two sides or a continuum? Gut. 61:794-7.
29. Alexander J, et al. (2001) Histopathological identification of colon cancer with microsatellite instability. Am. J. Pathol. 158:527-35.
30. Phillips SM, et al. (2004) Tumour-infiltrating lymphocytes in colorectal cancer with microsatellite instability are activated and cytotoxic. Br. J. Surg. 91:469-75.
31. Deschoolmeester V, Baay M, Lardon F, Pauwels P, Peeters M. (2011) Immune cells in colorectal cancer: prognostic relevance and role of MSI. Cancer Microenviron. 4:377-92.
32. Nosho K, et al. (2010) Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review. J. Pathol. 222:350-66.
33. Parsons HM, et al. (2011) Association between lymph node evaluation for colon cancer and node positivity over the past 20 years. JAMA. 306:1089-97.
34. Porter GA, et al. (2012) Improving nodal harvest in colorectal cancer: so what? Ann. Surg. Oncol. 19:1066-73.
35. Nash GM, et al. (2011) A predictive model for lymph node yield in colon cancer resection specimens. Ann. Surg. 253:318-22.